Loading clinical trials...

Comparison of AOCT and AOPT for the Treatment of Medial Large Cystic OLT | Clinical Trials | Clareo Health

COMPLETEDNCT04950335

Comparison of AOCT and AOPT for the Treatment of Medial Large Cystic OLT

Autologous osteoperiosteal transplantation using tissue harvested from the iliac crest is used to treat large cystic osteochondral lesions of the talus. This study is to compare clinical and radiologi...

Lead sponsor: Peking University Third Hospital•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

Not Yet RecruitingPhase 1

The Effect of Platelet Rich Plasma for the Treatment of Osteochondral Lesions of the Talus

NCT05795660 · Osteochondral Lesions of the Talus

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 6, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment46

Start dateMar 2014

Last updatedJul 6, 2021

Condition

Osteochondral Lesions of the Talus

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 6, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions